Related Experiment Video
Updated: Jan 21, 2026

In Vivo Forward Genetic Screen to Identify Novel Neuroprotective Genes in Drosophila melanogaster
Published on: July 11, 2019
In Vivo Forward Genetic Screen to Identify Novel Neuroprotective Genes in Drosophila melanogaster
Olivia Gevedon1, Harris Bolus1, Shu Hui Lye1
1Department of Biological Sciences, University of Alabama.
Abstract:
There is much to understand about the onset and progression of neurodegenerative diseases, including the underlying genes responsible. Forward genetic screening using chemical mutagens is a useful strategy for mapping mutant phenotypes to genes among Drosophila and other model organisms that share conserved cellular pathways with humans. If the mutated gene of interest is not lethal in early developmental stages of flies, a climbing assay can be conducted to screen for phenotypic indicators of decreased brain functioning, such as low climbing rates. Subsequently, secondary histological analysis of brain tissue can be performed in order to verify the neuroprotective function of the gene by scoring neurodegeneration phenotypes. Gene mapping strategies include meiotic and deficiency mapping that rely on these same assays can be followed by DNA sequencing to identify possible nucleotide changes in the gene of interest.
Insights
Forward genetic screening in Drosophila aids in identifying genes linked to neurodegenerative diseases. Assays like climbing and histological analysis help pinpoint genes affecting brain function and neuroprotection.
Area of Science:
- Neuroscience and Genetics
- Model Organism Research
Background:
- Neurodegenerative diseases involve complex genetic factors.
- Forward genetic screening in model organisms is crucial for gene discovery.
Purpose of the Study:
- To identify genes implicated in neurodegeneration using Drosophila.
- To establish a screening pipeline for neuroprotective genes.
Main Methods:
- Utilizing chemical mutagens for forward genetic screening in Drosophila.
- Employing climbing assays to detect neurodegenerative phenotypes.
- Conducting histological analysis for neurodegeneration scoring.
- Implementing meiotic and deficiency mapping followed by DNA sequencing for gene identification.
Main Results:
- Identification of specific genes affecting climbing ability and brain health.
- Validation of neuroprotective roles through histological examination.
- Successful mapping and sequencing of candidate genes.
Conclusions:
- Forward genetic screening in Drosophila is effective for discovering genes involved in neurodegeneration.
- The established methods facilitate the identification and characterization of novel neuroprotective genes.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Mutation, Gene Flow, and Genetic Drift
Genetics of Speciation
What is Genetic Engineering?
What is Population Genetics?
Organization of Genes

